Results

Total Results: 344 records

Showing results for "liver".
Users also searched for: hepatitis c

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
    May 02, 2011 - amyloidosis  Amyloid-related systemic syndrome — organ involvement by tissue amyloid deposition (renal, liver
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/malnutrition-hospitalized-adults-protocol.pdf
    October 19, 2020 - subsequent malabsorption, including ulcerative colitis and Crohn’s disease • Patients with chronic liver
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
    October 01, 2016 - follow-up formulae � Exclude parenterally administered sources o Marine oils, including fish oil, cod liver … from the original review, reported on supplementation for lactating women, including fish oil, cod liver
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - Harms included spotting, elevations in liver function enzymes, and endometrial hyperplasia. … Ulipristal was associated with hot flashes, hyperplasia, and increases in liver function enzymes, although
  5. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
    January 01, 2012 - Long-term PN can lead to serious side effects such as liver damage, the risk of which increases the … with SBS is 30%. 53 Long-term parenteral nutrition (PN) can lead to serious side effects such as liver
  6. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - For example, several individuals reporting later-onset PXE after a liver transplant precipitated the … Acquired pseudoxanthoma elasticum presenting after liver transplantation.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
    August 09, 2013 - differentiating an inflammatory pancreatic mass from pancreatic adenocarcinoma, or detecting metastases to the liver … Metastases – Spread of the primary pancreatic tumor to other distant parts of the body (e.g., liver
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
    September 30, 2015 - contraindicated with methadone or buprenorphine; history of methadone/buprenorphine maintenance; pregnant; liver
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
    January 01, 2024 - Other risks of anticoagulant use include liver injury,17 minor bleeding,18 and dermatologic effects.19 … patients on DOACs, including urea and electrolytes (3 monthly to annually), full blood count, and liver … Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-future_research.pdf
    January 01, 2020 - authors included cardiovascular disease, diabetes mellitus, infertility, degenerative joint disease, and liver … ClinicalTrials.gov/show/NCT00169702 Recently Completed Effect of Dietary and Life Style Modification on Post Liver
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
    November 03, 2014 - • Inflammatory effects, including skin rash • Hematologic effects • Cardiovascular effects • Liver
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
    October 01, 2018 - interventions with important adverse effects; such as nefazodone (which can be associated with sudden onset liver
  13. S96 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
    October 01, 2007 - ORIGINAL ARTICLE Evaluation and Overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES) Michael A. Jhung, MD, MPH,* Daniel S. Budnitz, MD, MPH,* Aaron B. Mendelsohn, PhD,*† Kelly N. Weidenbach, MPH,* Theresa D. Nelson, MS,‡ and Daniel A. Polloc…
  14. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
    January 01, 2023 - The damage may be either physical (e.g., liver damage from chronic drinking) or mental/social (e.g. … rates of early mortality.19-21 They are associated with hypertension, heart disease, stroke, cancer, liver
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - pneumococcal and influenza vaccines to prevent serious health complications in adults with chronic liver … Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
    April 25, 2013 - Hg if there is evidence for increased stroke volume which occurs commonly in patients with anxiety, liver … KQ1L For echocardiography, screening populations were SSc, liver transplant and Sickle cell disease. … For liver transplants, diagnostic criteria use PVR>120 for several studies which may be too low. … KQ2: These studies rely heavily on SSc and liver disease. Few studies of IPAH.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - Pulmonary circulation disorders, Paralysis, Other neurologic disorders, Chronic pulmonary disease, Liver
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
    April 01, 2013 - sensitivity 0.91 [95% CI, 0.85 to 0.94]; specificity 0.91 [95% CI, 0.85 to 0.94]) included 4 studies of liver … (This is shown in studies of liver transplant patients with complete verification).
  19. effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
    August 27, 2012 - How far would we have to increase the risk of liver failure to take away that 0.84 gain in benefit from … and the answer is that patients would tolerate up to a little more than 2% increase in the chance of liver
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
    May 01, 2013 - Am J Physiol Gastrointest Liver Physiol. 2009;297(6):G1107-14. PMID: 19808653. 49. … Am J Physiol Gastrointest Liver Physiol. 2010;299(6):G1276-86. PMID: 20847301. 65.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: